{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-26-003459","form_type":"8-K","ticker":"EDSA","cik":"0001540159","company_name":"Edesa Biotech, Inc.","filed_at":"2026-05-15T13:08:56+00:00","discovered_at":"2026-05-15T13:10:00.276691+00:00","generated_at":"2026-05-15T13:10:11.626252+00:00","sec_items":["5.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Edesa Biotech CEO to receive 90% of salary as RSUs, up from 50%","bullets":["CEO Pardeep Nijhawan will receive 90% of monthly base salary as fully vested RSUs, effective May 13, 2026.","Previously, 50% of base salary was issued as RSUs; remaining 10% paid in cash for withholding and tax requirements.","RSUs granted each month at month-end fair market value under the 2019 Equity Incentive Compensation Plan."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-26-003459","json":"https://secwatch.observer/filing/0001171843-26-003459.json","markdown":"https://secwatch.observer/filing/0001171843-26-003459.md","text":"https://secwatch.observer/filing/0001171843-26-003459.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1540159/000117184326003459/0001171843-26-003459-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1540159/000117184326003459/f8k_051526.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T13:10:11.626252+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}